(MRS / MRSI - Magnetic Resonance Spectroscopic Imaging) A method using the NMR phenomenon to identify the chemical state of various elements without destroying the sample. MRS therefore provides information about the chemical composition of the tissues and the changes in chemical composition, which may occur with disease processes.
Although MRS is primarily employed as a research tool and has yet to achieve widespread acceptance in routine clinical practice, there is a growing realization that a noninvasive technique, which monitors disease biochemistry can provide important new information for the clinician.
The underlying principle of MRS is that atomic nuclei are surrounded by a cloud of electrons, which very slightly shield the nucleus from any external magnetic field. As the structure of the electron cloud is specific to an individual molecule or compound, then the magnitude of this screening effect is also a characteristic of the chemical environment of individual nuclei.
In view of the fact that the resonant frequency is proportional to the magnetic field that it experiences, it follows that the resonant frequency will be determined not only by the external applied field, but also by the small field shift generated by the electron cloud. This shift in frequency is called the chemical shift (see also Chemical Shift). It should be noted that chemical shift is a very small effect, usually expressed in ppm of the main frequency. In order to resolve the different chemical species, it is therefore necessary to achieve very high levels of homogeneity of the main magnetic field B0. Spectra from humans usually require shimming the magnet to approximately one part in 100. High resolution spectra of liquid samples demand a homogeneity of about one part in 1000.
In addition to the effects of factors such as relaxation times that can affect the NMR signal, as seen in magnetic resonance imaging, effects such as J-modulation or the transfer of magnetization after selective excitation of particular spectral lines can affect the relative strengths of spectral lines.
In the context of human MRS, two nuclei are of particular interest - H-1 and P-31. (PMRS - Proton Magnetic Resonance Spectroscopy) PMRS is mainly employed in studies of the brain where prominent peaks arise from NAA, choline containing compounds, creatine and creatine phosphate, myo-inositol and, if present, lactate; phosphorus 31 MR spectroscopy detects compounds involved in energy metabolism (creatine phosphate, adenosine triphosphate and inorganic phosphate) and certain compounds related to membrane synthesis and degradation. The frequencies of certain lines may also be affected by factors such as the local pH. It is also possible to determine intracellular pH because the inorganic phosphate peak position is pH sensitive.
If the field is uniform over the volume of the sample, "similar" nuclei will contribute a particular frequency component to the detected response signal irrespective of their individual positions in the sample. Since nuclei of different elements resonate at different frequencies, each element in the sample contributes a different frequency component. A chemical analysis can then be conducted by analyzing the MR response signal into its frequency components.

See also Spectroscopy.

Quick Overview

Ferromagnetic metal will cause a magnetic field inhomogeneity, which in turn causes a local signal void, often accompanied by an area of high signal intensity, as well as a distortion of the image. They create their own magnetic field and dramatically alter precession frequencies of protons in the adjacent tissues. Tissues adjacent to ferromagnetic components become influenced by the induced magnetic field of the metal hardware rather than the parent field and, therefore, either fail to precess or do so at a different frequency and hence do not generate useful signal. Two components contribute to susceptibility artifact, induced magnetism in the ferromagnetic component itself and induced magnetism in protons adjacent to the component.
Artifacts from metal may have varied appearances on MRI scans due to different type of metal or configuration of the piece of metal. The biocompatibility of metallic alloys, stainless steel, cobalt chrome and titanium alloy is based on the presence of a constituent element within the alloy that has the ability to form an adherent oxide coating that is stable, chemically inert and hence biocompatible. In relation to imaging titanium alloys are less ferromagnetic than both cobalt and stainless steel, induce less susceptibility artifact and result in less marked image degradation.

Remove the metal when possible or take a not so sensitive sequence (a SE or another sequence with a rephasing 180° pulse).

See also Susceptibility Artifact.

Quick Overview

A moiré pattern is an interference pattern created for example when two grids are overlaid at an angle, or when they have slightly different mesh sizes. The human visual system creates an imaginary pattern of roughly horizontal dark and light bands, the moiré pattern that appears to be superimposed on the lines.
In MRI, the appearance of moiré fringes can be caused by a variety of reasons e.g., inhomogeneity of the main magnetic field caused by a defect shielding (interference with RF pulses), interferences produced by aliasing, and interferences of echoes from different excitation modes (with different echo times).

Take spin echo-based techniques, or a surface coil. This artifact is often sensitive to shimming or susceptibility gradients.

Quick Overview
Please note that there are different common names for this artifact.

Patient motion is the largest physiological effect that causes artifacts, often resulting from involuntary movements (e.g. respiration, cardiac motion and blood flow, eye movements and swallowing) and minor subject movements.
Movement of the object being imaged during the sequence results in inconsistencies in phase and amplitude, which lead to blurring and ghosting. The nature of the artifact depends on the timing of the motion with respect to the acquisition. Causes of motion artifacts can also be mechanical vibrations, cryogen boiling, large iron objects moving in the fringe field (e.g. an elevator), loose connections anywhere, pulse timing variations, as well as sample motion. These artifacts appear in the phase encoding direction, independent of the direction of the motion.

Motion artifacts can be flipped 90° by swapping the phase//frequency encoding directions.
The artifacts can be reduced by using breath holding, cardiac synchronization or respiratory compensation techniques: triggering, gating, retrospective triggering or phase encoding artifact reduction. Flow effects can be reduced by using gradient moment nulling of the first order of flow, gradient moment rephasing or flow compensation, depending of the MRI system.
Peristaltic motion can be reduced with the intravenous injection of an anti-spasmodic (e.g. Buscopan).
By using multiple averages, respiratory motion can be reduced in the same way that multiple averages increase the signal to noise ratio. Noticeable motion averaging is seen when four averages are obtained, six averages are often as good as respiratory compensation techniques and higher averages will continue to improve image quality.
In some cases will help a presaturation of the anatomy that was generating the motion.

See also Phase Encoded Motion Artifact.

(LE) Myocardial late enhancement in contrast enhanced cardiac MRI has the ability to precisely delineate myocardial scar associated with coronary artery disease. Viability imaging implies evaluating infarcted myocardium to see whether there is enough viable tissue available for revascularization. The reversal of myocardial dysfunction is particularly relevant in patients with depressed ventricular function because revascularization improves long-term survival. In comparison to SPECT and PET imaging, myocardial late enhancement MRI demonstrates areas of delayed enhancement exactly in correlation with the infarcted region.
Viability on cardiac MRI (CMR) is based on the fact that all infarcts enhance vividly 10-15 minutes after the administration of intravenous paramagnetic contrast agents. This enhancement represents the accumulation of gadolinium in the extracellular space, due to the loss of membrane integrity in the infarcted tissue. This phenomenon of delayed hyperenhancement has been proven to correlate with the actual extent of the infarct.
MRI myocardial late enhancement can quantify the size, location and transmural extent of the infarct. If the transmural extent of the infarct (region of enhancement on MRI) is less than 50% of the wall thickness, there will be improved contractility in that segment following revascularization. In areas of hypokinesia, if there is a rim of "black" or non-infarcted myocardium that is not contracting well, it indicates the presence of hibernating myocardium, which is likely to improve after revascularization of the artery supplying that particular territory.
The total duration of a myocardial late enhancement MR imaging protocol for viability is approximately 30 minutes, including scout images, first-pass images, cine images in two planes, and delayed myocardial enhancement images. In order to assess viable myocardium, the gadolinium contrast agent is injected at a dose of 0.15 to 0.2 mmol/kg. After about 10 minutes, short axis and long axis views (see cardiac axes) of the heart are obtained using an inversion prepared ECG gated gradient echo sequence. The inversion pulse is adjusted to suppress normal myocardium. Areas of nonviable myocardium retain extremely high signal intensity, black areas show normal tissue.

For Ultrasound Imaging (USI) see Myocardial Contrast Echocardiography at Medical-Ultrasound-Imaging.com.